The World Health Organization Classification
of Odontogenic Lesions:
A Summary of the Changes of the 2022 (5th) Edition

Soluk Tekkesin, Merva; Wright, John

doi:10.5146/tjpath.2022.01573

The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition

MERVA SOLUK TEKKEŞİN, (İstanbul Üniversitesi, Onkoloji Enstitüsü, Tümör Patolojisi Anabilim Dalı,İstanbul, Türkiye)

John M. WRIGHT (Department of Diagnostic Sciences, School of Dentistry, Texas A&M University, DALLAS, United State)

Türk Patoloji Dergisi

0 0

Yıl: 2022 Cilt: 38 Sayı: 2 Sayfa Aralığı: 168 - 184 Metin Dili: İngilizce DOI: 10.5146/tjpath.2022.01573 İndeks Tarihi: 29-06-2022

The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition

Öz:

The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumors opened to online access in March 2022. This edition is conceptually similar to the previous classification of odontogenic lesions. The only newly defined entity in odontogenic lesions is adenoid ameloblastoma, which is classified under benign epithelial odontogenic tumors. While not odontogenic, the surgical ciliated cyst is a new entry to the cyst classification of the jaws. In other respects, a very important change was made in the new blue books that added ‘essential and desirable diagnostic criteria’ for each entity to highlight the features considered indispensable for diagnosis. In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık

1. WHO Classification of Tumours Editorial Board. Head and neck tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 9). Available from: https://tumourclassification.iarc.who.int/chapters/52.
2. Vered M, Wright JM. Update from the 5th Edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol. 2022;16:63-75.
3. Soluk-Tekkeşin M, Wright JM. The World Health Organization classification of odontogenic lesions: A summary of the changes of the 2017 (4th) edition. Turk Patoloji Derg. 2018;34(1).
4. Odontogenic and maxilofacial bone tumours. In: El-naggar ak, Chan JkC, Grandis Jr, Takata T, Slootweg P, editors. WHO classification of head and neck tumours. 4th ed. lyon: IARC; 2017. 205-60.
5. Loyola AM, Cardoso SV, de Faria PR, Servato JP, Eisenberg AL, Dias FL, Thavaraj S, Gomes CC, Gomez RS. Adenoid ameloblastoma: Clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:368-77.
6. Vargas PA, Carlos-Bregni R, Mosqueda-Taylor A, Cuairan- Ruidíaz V, Lopes MA, de Almeida OP. Adenomatoid dentinoma or adenomatoid odontogenic hamartoma: What is the better term to denominate this uncommon odontogenic lesion? Oral Dis. 2006;12:200-3.
7. Mosqueda-Taylor A, Carlos-Bregni R, Ledesma-Montes C, Fillipi RZ, de Almeida OP, Vargas PA. Calcifying epithelial odontogenic tumor-like areas are common findings in adenomatoid odontogenic tumors and not a specific entity. Oral Oncol. 2005;41:214-5.
8. Coura BP, Bernardes VF, de Sousa SF, França JA, Pereira NB, Pontes HAR, Batista AC, da Cruz Perez DE, Albuquerque Junior RLC, de Souza LB, Martins MD, Diniz MG, Gomez RS, Gomes CC. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features. Mod Pathol. 2019;32:799-806.
9. Zhou CX, Li TJ. A clinicopathologic study on central odontogenic fibroma: With special reference to amyloid variant. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126:513-20.
10. Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol. 1998;34:317-25.
11. Heikinheimo K, Huhtala JM, Thiel A, Kurppa KJ, Heikinheimo H, Kovac M, Kragelund C, Warfvinge G, Dawson H, Elenius K, Ristimäki A, Baumhoer D, Morgan PR. The mutational profile of unicystic ameloblastoma. J Dent Res. 2019;98:54-60.
12. Zlotogorski-Hurvitz A, Soluk Tekkeşin M, Passador-Santos F, Martins Montalli VA, Salo T, Mauramo M, Kats L, Buchner A, Vered M. Conceptual changes in ameloblastoma: Suggested reclassification of a “veteran” tumor. Oral Dis. 2022;28:703-10.
13. Hirschhorn A, Campino GA, Vered M, Greenberg G, Yacobi R, Yahalom R, Barshack I, Toren A, Amariglio N, Rechavi G. Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration. J Tissue Eng Regen Med. 2021;15:1155-61.
14. Brown NA, Betz BL. Ameloblastoma: A review of recent molecular pathogenetic discoveries. Biomark Cancer. 2015;7(Suppl 2):19-24.
15. Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492-8.
16. Kaye FJ, Ivey AM, Drane WE, Mendenhall WM, Allan RW. Clinical and radiographic response with combined BRAFtargeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2014;107:378.
17. Jayasooriya PR, Abeyasinghe WAMUL, Liyanage RLPR, Uthpali GN, Tilakaratne WM. Diagnostic enigma of adenoid ameloblastoma: Literature review based evidence to consider it as a new sub type of ameloblastoma. Head Neck Pathol. 2021 Jul 19.
18. Adorno-Farias D, Muniz VRVM, Soares AP, Cury PR, Rabelo RG, Fernández-Ramires R, de Azevedo RA, Dos Santos JN. Ameloblastoma with adenoid features: A series of eight cases. Acta Histochem. 2018;120:468-76.
19. Odontogenic tumors. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. World Health Organization classification. Pathology and genetics of head and neck tumors. 3rd ed. lyon: IarC Press; 2005. 283-327.
20. Coura BP, Bernardes VF, de Sousa SF, Diniz MG, Moreira RG, de Andrade BAB, Romañach MJ, Pontes HAR, Gomez RS, Odell EW, Gomes CC. Targeted next-generation sequencing and allelespecific quantitative PCR of laser capture microdissected samples uncover molecular differences in mixed odontogenic tumors. J Mol Diagn. 2020;22:1393-9.
21. Kirjavainen A, Tuovinen V, Sándor GK. Large ameloblastic fibro-odontoma in a 7-year-old girl with analysis of 108 cases. Ann Maxillofac Surg. 2016;6:15-20.
22. Soluk-Tekkesin M, Vered M. Ameloblastic fibro-odontoma: At the crossroad between “developing odontoma” and true odontogenic tumour. Head Neck Pathol. 2021;15:1202-11.
23. Lam SW, Cleven AHG, Briaire-de Bruijn IH, Schreuder WH, Kroon HM, Savci-Heijink DC, Suurmeijer AJH, Szuhai K, Bovée JVMG, Baumhoer D. FOS rearrangement and expression in cementoblastoma. Am J Surg Pathol. 2021;45:690-3.
24. Pereira TDSF, Diniz MG, França JA, Moreira RG, Menezes GHF, Sousa SF, Castro WH, Gomes CC, Gomez RS. The Wnt/β- catenin pathway is deregulated in cemento-ossifying fibromas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:172-8.
25. Pereira NB, Bastos VC, de Souza JC, Diniz MG, Vitório JG, Kitten GT, de Oliveira Andrade L, de Avelar GF, Castro WH, Bernardes VF, Dias AAM, Gomez RS, Gomes CC. First insights for targeted therapies in odontogenic myxoma. Clin Oral Investig. 2020;24:2451-8.
26. Slootweg PJ, Odell EW, Baumhoer D, Carlos R, Hunter KD, Taylor AM, Richardson MS, Slater L, Speight PM, Wright J, Thompson LDR. Data set for the reporting of malignant odontogenic tumors: Explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2019;143:587-92.
27. Koutlas IG, Allen CM, Warnock GR, Manivel JC. Sclerosing odontogenic carcinoma: A previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential. Am J Surg Pathol. 2008;32:1613-9.
28. Niu Z, Li Y, Chen W, Zhao J, Zheng H, Deng Q, Zha Z, Zhu H, Sun Q, Su L. Study on clinical and biological characteristics of ameloblastic carcinoma. Orphanet J Rare Dis. 2020;15:316.
29. Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, Barker B, Seethala RR. Clear cell odontogenic carcinomas show EWSR1 rearrangements: A novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol. 2013;37:1001-5.
30. Antonescu CR, Katabi N, Zhang L, Sung YS, Seethala RR, Jordan RC, Perez-Ordoñez B, Have C, Asa SL, Leong IT, Bradley G, Klieb H, Weinreb I. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50:559-70.
31. Rappaport MJ, Showell DL, Edenfield WJ. Metastatic ghost cell odontogenic carcinoma: Description of a case and search for actionable targets. Rare Tumors. 2015;7:5813.
32. Bose P, Pleasance ED, Jones M, Shen Y, Ch’ng C, Reisle C, Schein JE, Mungall AJ, Moore R, Ma Y, Sheffield BS, Thomson T, Rasmussen S, Ng T, Yip S, Lee CW, Ho C, Laskin J, Marra MA, Jones SJ. Integrative genomic analysis of ghost cell odontogenic carcinoma. Oral Oncol. 2015;51:e71-5.
33. de Morais EF, Carlan LM, de Farias Morais HG, Pinheiro JC, Martins HDD, Barboza CAG, de Almeida Freitas R. Primary intraosseous squamous cell carcinoma involving the jaw bones: A systematic review and update. Head Neck Pathol. 2021;15:608- 16.
34. McLean-Holden AC, Bishop JA, Kessler HP, Myers LL, Radwan AM, Wildey TC, Wright JM, Cheng YL. Spindle-cell variant of ameloblastic carcinoma: A report of 3 cases and demonstration of epithelial-mesenchymal transition in tumor progression. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128:e113-e121.
35. Chrcanovic BR, Brennan PA, Rahimi S, Gomez RS. Ameloblastic fibroma and ameloblastic fibrosarcoma: A systematic review. J Oral Pathol Med. 2018;47:315-25.
36. Mosqueda-Taylor A, Neville BW, Tatemoto Y, Ogawa I, Takata T. Odontogenic carcinoma with dentinoid: A new odontogenic carcinoma. Head Neck Pathol. 2014;8:421-31.
37. Tekkesin MS, Olgac V, Aksakalli N, Alatli C. Odontogenic and nonodontogenic cysts in Istanbul: Analysis of 5088 cases. Head Neck. 2012;34:852-5.
38. Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH, Gomes CC, Gomez RS. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med. 2016;45:780-5.
39. Nel C, Robinson L, Roza ALOC, Vargas PA, Nortjé CJ, van Heerden WF. Calcifying odontogenic cysts: A 20-year retrospective clinical and radiological review. Dentomaxillofac Radiol. 2021;50:20200586.
40. Yukimori A, Oikawa Y, Morita KI, Nguyen CT, Harada H, Yamaguchi S, Kayamori K, Yamaguchi A, Ikeda T, Sakamoto K. Genetic basis of calcifying cystic odontogenic tumors. PLoS One. 2017;12:e0180224.
41. Fowler CB, Brannon RB, Kessler HP, Castle JT, Kahn MA. Glandular odontogenic cyst: Analysis of 46 cases with special emphasis on microscopic criteria for diagnosis. Head Neck Pathol. 2011;5:364-75.
42. Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: A finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol. 2014;8:287-90.
43. Greer RO, Eskendri J, Freedman P, Ahmadian M, Murakami- Walter A, Varella-Garcia M. Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: Histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases. J Oral Pathol Med. 2018;47:192-7.
44. Li TJ. The odontogenic keratocyst: A cyst, or a cystic neoplasm? J Dent Res. 2011;90:133-42.
45. Qu J, Yu F, Hong Y, Guo Y, Sun L, Li X, Zhang J, Zhang H, Shi R, Chen F, Li T. Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors. Oral Oncol. 2015;51:40-5.
46. Qu J, Zhang J, Zhang H, Li X, Hong Y, Zhai J, Wang Y, Chen F, Li T. PTCH1 alterations are frequent but other genetic alterations are rare in sporadic odontogenic keratocysts. Oral Dis. 2019;25:1600-7.
47. Kahn A, Matalon S, Bassam Salem R, Kats L, Chaushu L, Vered M, Rosen E. Sinus floor augmentation—associated surgical ciliated cysts: Case series and a systematic review of the literature. Appl Sci. 2021;11:1903.
48. Bourgeois SL Jr, Nelson BL. Surgical ciliated cyst of the mandible secondary to simultaneous Le Fort I osteotomy and genioplasty: Report of case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:36-9.
49. Daley TD, Wysocki GP, Pringle GA. Relative incidence of odontogenic tumors and oral and jaw cysts in a Canadian population. Oral Surg Oral Med Oral Pathol. 1994;77:276-80.

APA	Soluk Tekkesin M, Wright J (2022). The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. , 168 - 184. 10.5146/tjpath.2022.01573
Chicago	Soluk Tekkesin Merva,Wright John The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. (2022): 168 - 184. 10.5146/tjpath.2022.01573
MLA	Soluk Tekkesin Merva,Wright John The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. , 2022, ss.168 - 184. 10.5146/tjpath.2022.01573
AMA	Soluk Tekkesin M,Wright J The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. . 2022; 168 - 184. 10.5146/tjpath.2022.01573
Vancouver	Soluk Tekkesin M,Wright J The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. . 2022; 168 - 184. 10.5146/tjpath.2022.01573
IEEE	Soluk Tekkesin M,Wright J "The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition." , ss.168 - 184, 2022. 10.5146/tjpath.2022.01573
ISNAD	Soluk Tekkesin, Merva - Wright, John. "The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition". (2022), 168-184. https://doi.org/10.5146/tjpath.2022.01573

APA	Soluk Tekkesin M, Wright J (2022). The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi, 38(2), 168 - 184. 10.5146/tjpath.2022.01573
Chicago	Soluk Tekkesin Merva,Wright John The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi 38, no.2 (2022): 168 - 184. 10.5146/tjpath.2022.01573
MLA	Soluk Tekkesin Merva,Wright John The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi, vol.38, no.2, 2022, ss.168 - 184. 10.5146/tjpath.2022.01573
AMA	Soluk Tekkesin M,Wright J The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi. 2022; 38(2): 168 - 184. 10.5146/tjpath.2022.01573
Vancouver	Soluk Tekkesin M,Wright J The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi. 2022; 38(2): 168 - 184. 10.5146/tjpath.2022.01573
IEEE	Soluk Tekkesin M,Wright J "The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition." Türk Patoloji Dergisi, 38, ss.168 - 184, 2022. 10.5146/tjpath.2022.01573
ISNAD	Soluk Tekkesin, Merva - Wright, John. "The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition". Türk Patoloji Dergisi 38/2 (2022), 168-184. https://doi.org/10.5146/tjpath.2022.01573